500
Participants
Start Date
November 28, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2026
FOLFOX-A
Patients will recieve nab-paclitaxel, oxaliplatin, Folinic Acid and 5-FU in a 14 day cycle
Gemcitabe and Abraxane
Patients will receive gemcitabine and nab-paclitaxel 3 weeks out of 4
G-CSF
Patients in the FOLFOX-A arm will also receive daily G-CSF as primary prophylaxis for all cycles. This will be given as per local site policy for 14 day chemotherapy regimens
RECRUITING
Aberdeen Royal Infirmary, Aberdeen
RECRUITING
Northern Ireland Cancer Centre, Belfast
RECRUITING
Queen Elizabeth Hospital, Birmingham
RECRUITING
Royal Bournemouth Hospital, Bournemouth
RECRUITING
Bristol Oncology Centre, Bristol
RECRUITING
Addenbrooke's Hospital, Cambridge
RECRUITING
Castle Hill Hospital, Cottingham
RECRUITING
Ninewells Hospital, Dundee
RECRUITING
Western General, Edinburgh
RECRUITING
Beatson West of Scotland Cancer Centre, Glasgow
RECRUITING
Raigmore Hospital, Inverness
RECRUITING
St James's University Hospital, Leeds
RECRUITING
Guy's Hospital, London
RECRUITING
Imperial College Healthcare Trust, London
RECRUITING
Royal Free London Hospital, London
RECRUITING
Royal Marsden Hospital, London
RECRUITING
St Bart's Hospital, London
RECRUITING
St George's Hospital, London
RECRUITING
University College London Hospital, London
RECRUITING
The Christie, Manchester, Manchester
RECRUITING
Milton Keynes General Hospital, Milton Keynes
RECRUITING
Freeman Hospital, Newcastle
RECRUITING
Nottingham University Hospital, Nottingham
RECRUITING
Churchill Hospital, Oxford
RECRUITING
Poole Hospital, Poole
RECRUITING
Weston Park, Sheffield
RECRUITING
University of Southampton Hospital, Southampton
RECRUITING
Singleton Hospital, Swansea
RECRUITING
Huddersfield Royal Infirmary, Huddersfield
RECRUITING
The Clatterbridge Cancer Centre, Liverpool
NHS Greater Glasgow and Clyde
OTHER
University of Glasgow
OTHER
Judith Dixon-Hughes
OTHER